Skip to main content
. 2017 Dec 5;12(12):e0189045. doi: 10.1371/journal.pone.0189045

Table 1. Characteristics of the study population according to RHI status.

Recent seroconversion
Characteristics Yes (RHI) No (NRHI) p-value Total
N 981 N 1627 N 2608
Age, years, median (IQR) 34 (28, 40) 36 (31, 42) <0.001 35 (30, 42)
Females, n (%) 117 (11.9%) 273 (16.8%) 1.000 390 (15.0%)
Mode of HIV Transmission, n (%) 0.501
IDUs 79 (8.1%) 164 (10.1%) 243 (9.4%)
Homosexual contacts 587 (59.9%) 893 (55.3%) 1480 (57.0%)
Heterosexual contacts 256 (26.1%) 489 (30.1%) 745 (28.6%)
Other/Unknown 58 (5.9%) 70 (4.3%) 128 (4.9%)
Not Italian nationality, n (%) 123 (12.5%) 212 (13.0%) 0.050 335 (12.8%)
AIDS diagnosis, n (%) 26 (2.7%) 67 (4.1%) 0.478 93 (3.6%)
CVD diagnosis, n (%) 3 (0.3%) 8 (0.5%) 0.295 11 (0.4%)
HBsAg, n (%) 0.036
Negative 947 (96.5%) 1582 (97.2%) 2529 (97.0%)
Positive 34 (3.5%) 45 (2.8%) 79 (3.0%)
Not tested 309 (31.5%) 553 (34.0%) 862 (33.1%)
HCV Ab, n (%) 0.161
Negative 606 (61.8%) 932 (57.3%) 1538 (59.0%)
Positive 80 (8.2%) 172 (10.6%) 252 (9.7%)
Not tested 295 (30.1%) 523 (32.1%) 818 (31.4%)
CD4 count, cells/mmc,
median (IQR)
493 (336, 667) 452 (289, 632) <0.001 469 (307, 651)
CD4 count nadir, cells/mmc,
median (IQR)
495 (338, 669) 452 (293, 625) <0.001 470 (309, 641)
CD8 count, cells/mmc,
median (IQR)
904 (654, 1284) 931 (688, 1283) 0.383 923 (675, 1283)
Viral load, log10 copies/mL,
median (IQR)
4.67 (4.06, 5.23) 4.42 (3.81, 4.97) <0.001 4.5 (3.89–5.07)
Time from HIV diagnosis to date of enrolment, months,
median (IQR)
6 (4, 9) 27 (18, 45) <0.001 17 (8, 32)
Site geographical position, n (%) 0.017
North 590 (60.1%) 916 (56.3%) 1506 (57.7%)
Center 313 (31.9%) 616 (37.9%) 929 (35.6%)
South 78 (8.0%) 95 (5.8%) 173 (6.6%)
Diabetes, n (%) 10 (1.0%) 16 (1.0%) <0.001 26 (1.0%)
Smoking, n (%) 0.950
No 327 (33.3%) 595 (36.6%) 922 (35.4%)
Yes 289 (29.5%) 592 (36.4%) 881 (33.8%)
Unknown 365 (37.2%) 440 (27.0%) 805 (30.9%)
Total cholesterol, mg/dL,
median (IQR)
165 (143, 192) 164 (140, 188) 0.395 165 (141, 189)
HDL cholesterol, mg/dL,
median (IQR)
42 (34, 48) 41 (33, 49) 0.673 41 (34, 48)
EGFR (CKD_Epi formula), ml/min/1.73m2, median (IQR) 4.67 (4.04, 5.17) 4.37 (3.63, 4.90) <0.001 4.45 (3.77, 5)
Blood glucose, mg/dL,
median (IQR)
86 (79, 92) 86 (80, 95) 0.037 86 (80, 94)
Use of statins, n (%) 5 (0.5%) 8 (0.5%) 0.353 13 (0.5%)
Use of blood pressure lowering drugs, n (%) 16 (1.6%) 35 (2.2%) 0.003 51 (2.0%)
Education, n (%) <0.001
Primary school 44 (4.5%) 55 (3.4%) 99 (3.8%)
Secondary school 194 (19.8%) 354 (21.8%) 548 (21.0%)
College 307 (31.3%) 580 (35.6%) 887 (34.0%)
University 157 (16.0%) 253 (15.6%) 410 (15.7%)
Other/Unknown 279 (28.4%) 385 (23.7%) 664 (25.5%)
Employment, n (%) <0.001
Unemployed 128 (13.0%) 194 (11.9%) 322 (12.3%)
Employed 454 (46.3%) 789 (48.5%) 1243 (47.7%)
Self-employed 138 (14.1%) 284 (17.5%) 422 (16.2%)
Occasional 31 (3.2%) 48 (3.0%) 79 (3.0%)
Student 63 (6.4%) 47 (2.9%) 110 (4.2%)
Retired 15 (1.5%) 35 (2.2%) 50 (1.9%)
Invalid 1 (0.1%) 2 (0.1%) 3 (0.1%)
Housewife 20 (2.0%) 46 (2.8%) 66 (2.5%)
Other/unknown 131 (13.4%) 182 (11.2%) 313 (12.0%)

LEGEND: Categorical data are presented as absolute numbers (percentages); p values for comparison of proportions between RHI and NRHI are by Chi-square test. Quantitative data are presented as median (Interquartile Range, IQR); p values for comparison of medians between RHI and NRHI are by Mann Whitney test. IDUs, Intravenous Drug Users; CVD, cardiovascular diseases; EGFR, glomerular filtration rate.